|
1
|
Xu CB, Shen JZ, Shen SF, Fu HY, Zhu YF and
Chen L: The significance of methylation status of secreted frizzled
related protein gene promoter in acute leukemia. Zhonghua Nei Ke Za
Zhi. 49:769–771. 2010.(In Chinese). PubMed/NCBI
|
|
2
|
Griffiths EA, Gore SD, Hooker C, McDevitt
MA, Karp JE, Smith BD, Mohammad HP, Ye Y, Herman JG and Carraway
HE: Acute myeloid leukemia is characterized by Wnt pathway
inhibitor promoter hypermethylation. Leuk Lyrephoma. 51:1711–1719.
2010. View Article : Google Scholar
|
|
3
|
Bai XL, Zhang Q, Ye LY, Liang F, Sun X,
Chen Y, Hu QD, Fu QH, Su W, Chen Z, et al: Myocyte enhancer factor
2C regulation of hepatocellular carcinoma via vascular endothelial
growth factor and Wnt/β-catenin signaling. Oncogene. 34:4089–4097.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kaveri D, Kastner P, Dembélé D, Nerlov C,
Chan S and Kirstetter P: β-Catenin activation synergizes with Pten
loss and Myc overexpression in Notch-independent T-ALL. Blood.
122:694–704. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shuai X, Zhou D, Shen T, Wu Y, Zhang J,
Wang X and Li Q: Overexpression of the novel oncogene SALL4 and
activation of the Wnt/beta-catenin pathway in myelodysplastic
syndromes. Cancer Genet Cytogenet. 194:119–124. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Valencia A, Román-Gómez J, Cervera J, Such
E, Barragán E, Bolufer P, Moscardó F, Sanz GF and Sanz MA: Wnt
signaling pathway is epigenetically regulated by methylation of Wnt
antagonists inacute myeloid leukemia. Leukemia. 23:1658–1666. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Román-Gómez J, Cordeu L, Agirre X,
Jiménez-Velasco A, San José-Eneriz E, Garate L, Calasanz MJ,
Heiniger A, Torres A and Prosper F: Epigenetic regulation of
Wnt-signaling pathway in acute lymphoblastic leukemia. Blood.
109:3462–3469. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ge X and Wang X: Role of Wnt canonical
pathway in hematological malignancies. J Hematol Oncol. 3:332010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Reya T, Duncan AW, Ailles L, Domen J,
Scherer DC, Willert K, Hintz L, Nusse R and Weissman IL: A role for
Wnt signalling in self-renewal of haematopoietic stem cells.
Nature. 423:409–414. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Weerkamp F, van Dongen JJ and Staal FJ:
Notch and Wnt signaling in T-lymphocyte development and acute
lymphoblastic leukemia. Leukemia. 20:1197–1205. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kawano Y and Kypta R: Secreted antagonists
of the Wnt signaling pathway. J Cell Sci. 116:2627–2634. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wodarz A and Nusse R: Mechanisms of Wnt
signaling in development. Ann Rev Cell Dev Biol. 14:59–88. 1998.
View Article : Google Scholar
|
|
13
|
Wang HL, Wang J, Xiao SY, Haydon R,
Stoiber D, He TC, Bissonnette M and Hart J: Elevated protein
expression of cyclin Di and Fra-I but decreased expression of c-Myc
in human colorectal adenoclu'cinomas overexpressing beta-catenin.
Int J Cancer. 101:301–310. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cadigan KM and Liu YI: Wnt signaling:
Complexity at the surface. J Cell Sci. 119:395–402. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pan FY, Zhang SZ, Xu N, Meng FL, Zhang HX,
Xue B, Han X and Li CJ: Beta-catenin signaling involves
HGF-enhanced HepG2 scattering through activating MMP-7
transcription. Histochem Cell Biol. 134:285–295. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM,
Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, et al: Use of arsenic
trioxide (As2O3) in the treatment of acute promyelocytic leukemia
(APL): II. Clinical efficacy and pharmacokinetics in relapsed
patients. Blood. 89:3354–3360. 1997.PubMed/NCBI
|
|
17
|
Berenson JR, Matous J, Swift RA, Mapes R,
Morrison B and Yeh HS: A phase I/II study of arsenic
trioxide/bortezomib/ascorbic acid combination therapy for the
treatment of relapsed or refractory multiple myeloma. Clin Cancer
Res. 13:1762–1768. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao WL, Chen SJ, Shen Y, Xu L, Cai X,
Chen GQ, Shen ZX, Chen Z and Wang ZY: Treatment of acute
promyelocytic leukemia with arsenic trioxide: Clinical and basic
studies. Leuk Lymphoma. 42:1265–1273. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tarkanyi I, Dudognon C, Hillion J, Pendino
F, Lanotte M, Aradi J and Ségal-Bendirdjian E: Retinoid/arsenic
combination therapy of promyelocytic leukemia: Induction of
telomerase-dependent cell death. Leukemia. 19:1806–1811. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Du J, Zhou N, Liu H, Jiang F, Wang Y, Hu
C, Qi H, Zhong C, Wang X and Li Z: Arsenic induces functional
reexpression of estrogen receptor α by demethylation of DNA in
estrogen receptor-negative human breast cancer. PloS One.
7:e359572012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xia J, Li Y, Yang Q, Mei C, Chen Z, Bao B,
Ahmad A, Miele L, Sarkar FH and Wang Z: Arsenic trioxide inhibits
cell growth and induces apoptosis through inactivation of notch
signaling pathway in breast cancer. Int J Mol Sci. 13:9627–9641.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thomas DJ, Nava GM, Cai SY, Boyer JL,
Hernández-Zavala A and Gaskins HR: Arsenic (+ 3 oxidation state)
methyltransferase and the methylation of arsenicals in the
invertebrate chordate Ciona intestinalis. Toxicol Sci. 113:70–76.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ji H, Li Y, Jiang F, Wang X, Zhang J, Shen
J and Yang X: Inhibition of transforming growth factor beta/SMAD
signal by MiR-155 is involved in arsenic trioxide-induced
anti-angiogenesis in prostate cancer. Cancer Sci. 105:1541–1549.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu TH, Raval A, Chen SS, Matkovic JJ,
Byrd JC and Plass C: CpG island methylation and expression of the
secreted frizzled-related protein gene family in chronic
lymphocytic leukemia. Cancer Res. 66:653–658. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chim CS, Chan WW, Pang A and Kwong YL:
Preferential methylation of Wnt inhibitory factor-1 in acute
promyelocytic leukemia: An independent poor prognostic factor.
Leukemia. 20:907–909. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Y, Zhu XX and Zhu CS: Abnormal
methylation patterns of SFRP1 gene in cells of leukemia and
inhibition of arsenic trioxide on the SFRP1 gene. Zhonghua Xue Ye
Xue Za Zhi. 34:157–159. 2013.(In Chinese). PubMed/NCBI
|
|
27
|
Wang Y, Zhu CS, Bi KH, Xu WW, Dong L and
Hou M: Study of WIF-1 promoter methylation with expressions of
β-catenin in acute leukemia. Zhonghua Yi Xue Za Zhi. 91:2858–2860.
2011.(In Chinese). PubMed/NCBI
|
|
28
|
Zhu XX, Zhu CS, Wang Y, Xu WW, Dong L, Guo
Y, Li H and Bi KH: Analysis of methylation of the Dickkopf1 (DKK-1)
gene in acute leukemia. Journal of Shandong University (Health
Sciences). 50:84–87. 2012.
|
|
29
|
Li H, Wang Y, Xu W, Dong L, Guo Y, Bi K
and Zhu C: Arsenic trioxide inhibits DNA methyltransferase and
restores TMS1 gene expression in K562 cells. Acta Haematol.
133:18–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fu HY, Shen JZ, Wu Y, Shen SF, Zhou HR and
Fan LP: Arsenic trioxide inhibits DNA methyltransferase and
restores expression of methylation-silenced CDKN2B/CDKN2A genes in
human hematologic malignant cells. Oncol Rep. 24:335–343.
2010.PubMed/NCBI
|
|
31
|
Nusse R and Varmus HE: Wnt genes. Cell.
69:1073–1087. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shen JZ, Xu CB, Fu HY, Wu DS, Zhou HR and
Fan LP: Methylation of secreted frizzled related protein gene in
acute leukemia patients in China. Asian Pac J Cancer Prev.
12:2617–2621. 2011.PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meng Z, Wang DM, Li YH, Liu X, Guo SQ and
Luo JM: Demethylation effect of inhibitor As2O3 on expression of
SHP-1 and C-kit genes in leukemia HL-60 cells. Zhongguo Shi Yan Xue
Ye Xue Za Zhi. 21:613–616. 2013.(In Chinese). PubMed/NCBI
|
|
35
|
Zhang XK, Luo JM and Sun J: Effect of
arsenic trioxide and 5-aza-2′-deoxycytidine on SHP-1, JAK3, TYK2
gene expression in K562 cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
22:323–328. 2014.(In Chinese). PubMed/NCBI
|
|
36
|
Cadigan KM: Wnt-beta-catenin signaling.
Curr Biol. 18:R943–R947. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Karim R, Tse G, Putti T, Scolyer R and Lee
S: The significance of the Wnt pathway in the pathology of human
cancers. Pathology. 36:120–128. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang X, Jia S, Yang S and Yang Y, Yang T
and Yang Y: Arsenic trioxide induces G2/M arrest in hepatocellular
carcinoma cel1s by increasing the tumor suppressor FTEN expression.
J Cell Biochem. 113:3528–3535. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Feala JD, Cortes J, Duxbury PM, McCulloch
AD, Piermarocchi C and Paternostro G: Statistical properties and
robustness of biological controller-target networks. PLoS One.
7:e293742012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dong X, Ma N, Liu M and Liu Z: Effects of
As2O3 nanoparticles on cell growth and apoptosis of NB4 cells. Exp
Ther Med. 10:1271–1276. 2015.PubMed/NCBI
|
